Found 1169 clinical trials
-
Phase 2 trial
-
Accepting adults
-
For all genders
-
Currently Recruiting
A Study to Evaluate the Effects of Basmisanil in Participants With Cognitive Impairment Associated With Schizophrenia (CIAS) Treated With Antipsychotics.
This multicenter study will assess the effects of 24 weeks of basmisanil treatment on cognition and functioning of stable schizophrenia participants treated with antipsychotics.
- 22 views
- 22 Dec, 2020
- 1 location
-
Accepting adults
-
For all genders
-
Currently Recruiting
A Washington University emotion and cognition research study is currently enrolling participants.
The purpose of the research study is to advance understanding of the effectiveness of emotion regulation (and therefore well-being) in later adulthood among those with mild cognitive impairment
- 0 views
- 01 Feb, 2021
- 1 location
-
Accepting Seniors
-
Accepting adults
-
For all genders
-
Psychiatry/Psychology
-
Currently Recruiting
Apathy and Reward Systems in Alzheimer’s Disease
This study is looking for people over the age of 65 who have either early stage Alzheimer’s/mild cognitive impairment or depression. The study is interested in examining cognition and brain
- 17 views
- 07 Dec, 2020
- 1 location
-
Accepting Seniors
-
Accepting adults
-
For all genders
-
Currently Recruiting
Wake Forest WF-1801 A Single Arm, Pilot Study of Ramipril for Preventing Radiation - Induced Cognitive Decline in Glioblastoma (GBM) Patients Receiving Brain Radiotherapy
People who were just diagnosed with glioblastoma and have yet to get treatment may be eligible. This trial is investigating whether a common blood pressure drug is helpful to prevent or diminish side effects of radiation when it is combined with the standard treatment for glioblastoma.
- 2 views
- 22 Dec, 2020
- 1 location
-
Accepting Seniors
-
Accepting adults
-
For all genders
-
Currently Recruiting
Is your memory loss just a sign of age, or something else?
Is your memory loss just a sign of age, or something else?
- 330 views
- 08 Dec, 2020
- 1 location
-
Accepting Seniors
-
Accepting adults
-
For all genders
-
Currently Recruiting
An Efficacy and Safety Study of LY3314814 in Early Alzheimer's Disease (AMARANTH)
An Efficacy and Safety Study of LY3314814 in Early Alzheimer's Disease (AMARANTH)
- 168 views
- 08 Dec, 2020
- 1 location
-
Phase 3 trial
-
Accepting Seniors
-
Accepting adults
-
For all genders
-
Currently Recruiting
A Phase 3 Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Aducanumab (BIIB037) in Subjects With Early Alzheimer's Disease
A Phase 3 Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Aducanumab (BIIB037) in Subjects With Early Alzheimer's Disease
- 62 views
- 08 Dec, 2020
- 1 location
-
Accepting Seniors
-
Accepting adults
-
For all genders
-
Currently Recruiting
Do you have Parkinson's disease and are you considering DBS?
Do you have Parkinson's disease and are you considering DBS?
- 552 views
- 23 Nov, 2020
- 1 location
-
Accepting Seniors
-
Accepting adults
-
For all genders
-
Psychiatry/Psychology
-
Currently Recruiting
Communication of Dementia Diagnoses: Investigating Patient, Family, and Physician Experiences and Developing Best Practices
This study involves a single interview of patients, caregivers, and health care professionals across Florida regarding their experiences in receiving and giving dementia diagnoses. The individual must live in Florida and have been diagnosed with dementia within the last 2 years to participate. Similarly, caregivers must live in Florida and …
- 37 views
- 23 Nov, 2020
- 1 location
-
Phase 1 trial
-
Accepting Seniors
-
Accepting adults
-
For all genders
-
Currently Recruiting
A Randomized, Double-Blinded, Placebo-Controlled Multiple Dose Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of BIIB037 in Subjects With Prodromal or Mild Alzheimer's Disease
A Randomized, Double-Blinded, Placebo-Controlled Multiple Dose Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of BIIB037 in Subjects With Prodromal or Mild Alzheimer's Disease
- 82 views
- 08 Dec, 2020
- 1 location